Variants of CTGF are associated with hepatic fibrosis in Chinese, Sudanese, and Brazilians infected with Schistosomes by Dessein, Alain et al.
The Rockefeller University Press  $30.00
J. Exp. Med. Vol. 206 No. 11  2321-2328
www.jem.org/cgi/doi/10.1084/jem.20090383
2321
BRIEF DEFINITIVE REPORT
Hepatointestinal schistosomiasis is caused by two 
species of helminths: Schistosoma japonicum, which 
is prevalent in Asia, and S. mansoni, which is 
prevalent in Africa and South America. Both 
worms develop in their host mesenteric system 
and lay eggs triggering inflammation in the he-
patic periportal space in which they are trapped. 
Worms live for years, and thus, chronic liver 
inflammation and significant tissue destruction 
are common in infected subjects. Tissue repair 
begins with the deposit of extracellular matrix 
proteins (ECMPs) in the damaged tissues, which 
are later replaced by normal hepatocytes. In some 
subjects, ECMPs accumulate in the periportal 
space, forming fibrosis deposits that reduce blood 
flow, causing varicose veins. Subjects die from 
the subsequent effects of hepatic fibrosis (HF). 
5–10% of the 350 million infected subjects may 
develop severe HF. There are no good markers 
for predicting HF progression in schistosome-
infected subjects. HF development is strongly 
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Abnormal fibrosis occurs during chronic hepatic inflammations and is the principal cause of 
death in hepatitis C virus and schistosome infections. Hepatic fibrosis (HF) may develop 
either slowly or rapidly in schistosome-infected subjects. This depends, in part, on a major 
genetic control exerted by genes of chromosome 6q23. A gene (connective tissue growth 
factor [CTGF]) is located in that region that encodes a strongly fibrogenic molecule. We 
show that the single nucleotide polymorphism (SNP) rs9402373 that lies close to CTGF is 
associated with severe HF (P = 2 × 106; odds ratio [OR] = 2.01; confidence interval of OR 
[CI] = 1.51–2.7) in two Chinese samples, in Sudanese, and in Brazilians infected with either 
Schistosoma japonicum or S. mansoni. Furthermore, SNP rs12526196, also located close to 
CTGF, is independently associated with severe fibrosis (P = 6 × 104; OR = 1.94; CI = 1.32–
2.82) in the Chinese and Sudanese subjects. Both variants affect nuclear factor binding and 
may alter gene transcription or transcript stability. The identified variants may be valuable 
markers for the prediction of disease progression, and identify a critical step in the devel-
opment of HF that could be a target for chemotherapy.
© 2009 Dessein et al.  This article is distributed under the terms of an Attribu-
tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.jem.org/misc/terms.shtml). After six 
months it is available under a Creative Commons License (Attribution–Noncom-
mercial–Share Alike 3.0 Unported license, as described at http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
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SNP rs1256196 also showed a trend for an association with 
this more severe disease phenotype (P = 0.12). Gender (P = 
0.001) was a significant covariate.
rs1257705, rs12526196, and rs9402373 polymorphisms 
are also associated with severe HF in Chinese farmers
We sought the replication of these results in an additional in-
dependent sample of Chinese farmers infected with S. japoni-
cum. The SNPs that showed evidence of an association with 
HF in fishermen were genotyped in farmers (113 controls and 
181 cases). The analysis of the SNPs separately showed associ-
ations between severe HF and SNPs rs9402373 (P = 0.003; 
OR = 2.2) and rs1256196 (P = 0.02; OR = 1.9; Table I). 
Other SNPs were not associated (P > 0.1). Multivariate analy-
sis of these SNPs simultaneously indicated that SNPs rs9402373 
(P = 0.03; OR = 2.3) and rs1256196 (P = 0.02; OR = 1.9) 
were independently associated with severe disease. Covariates 
were birthplace (endemic or not endemic: P = 0.03) and in-
fection with hepatitis B virus (HBV; P = 0.05).
We next investigated whether HF caused by S. mansoni in 
endemic subjects in Sudan and Brazil was also affected by 
CTGF allelic variants. CTGF polymorphisms associated with 
HF in Chinese fishermen were genotyped in both samples.
rs1257705, rs12526196, and rs9402373 polymorphisms 
are also associated with severe HF in Sudanese patients
In Sudanese and Brazilian samples, the minor SNP 1256196 
allele frequencies (4.4 and 6.6%, respectively) were lower than 
in Chinese fishermen and farmers (17.03 and 16.52%, respec-
tively); this and smaller sample sizes reduced (from >74% in 
Chinese to <20% in Sudanese and Brazilians) the power to 
detect an association with the SNP rs12526196. Nevertheless, 
the analysis (Table II, left) in Sudanese patients (152 controls 
and 62 cases) suggested the association of rs1256196 (P = 
0.066; OR = 6.8) with HF and indicated the association of 
rs9402373 (P = 0.008; OR = 5.2) with HF. An additional as-
sociation was found for rs12527705 (P = 0.069; OR = 6.7). 
Multivariate analysis of these SNPs simultaneously indicated 
that SNPs rs9402373 (P = 0.008; OR = 5.2) and rs1256196 
(P = 0.059; OR = 7.3) were independently associated with 
HF in the presence of age as a covariate (P = 0.05).
rs6918698 and rs9402373 polymorphisms are associated 
with severe HF in Brazilian patients
Genotyping data analysis of the Brazilian patients (61 cases 
and 75 controls) showed (Table II, right) that SNPs rs9402373 
(P = 0.02; OR = 2.6) and rs6918698 (P = 0.008; OR = 3) 
were associated with HF without additional covariates. The 
genotypes associated with disease for both SNPs were similar 
to those observed in Chinese and Sudanese subjects. Multi-
variate analysis indicated that SNPs rs9402373 (P = 9 × 104; 
OR = 4.3) and rs6918698 (P = 5 × 104; OR = 4.9) were 
independently associated with HF in Brazilians.
We performed a meta-analysis with SNP rs9402373 on 
the data obtained in the four samples. No covariates were in-
cluded in the analysis. The meta-analysis confirmed that the 
influenced by a major locus located at chromosome 6q23 
(Dessein et al., 1999). This region contains two major candi-
date genes: IFNGR1 encodes a chain of the IFN- receptor 
(IFN- being an antifibrogenic cytokine that protects against 
HF; Henri et al., 2002; Chevillard et al., 2003); and connec-
tive tissue growth factor (CTGF), which encodes a profibro-
genic molecule produced by hepatocytes (Kobayashi et al., 
2005; Gressner et al., 2007), hepatic stellate cells, myofibro-
blasts, and endothelial cells (Gressner and Gressner, 2008). 
CTGF transcripts are overexpressed in livers affected by fibro-
sis of various etiologies (Rachfal and Brigstock, 2003). In this 
report,  functional  single  nucleotide  polymorphisms  (SNPs) 
implicate CTGF as a major actor in severe HF in schistosome-
infected Chinese, Sudanese, and Brazilian subjects.
RESULTS AND DISCUSSION
Several independent polymorphisms are associated  
with severe HF in Chinese fishermen
We first studied HF in Chinese fishermen infected with   
S. japonicum. Covariates influencing the development of HF 
were gender, exposure, and antischistosome treatments. We used 
these covariates to test, in 99 cases and 201 controls, whether 
SNPs (three SNPs per gene) in CTGF and IFNGR1 were as-
sociated with HF. SNP rs9399005 in close proximity to CTGF 
was associated with HF (P = 0.02). Sequencing CTGF (3.2 kb), 
15.3 kb of sequence upstream from the starting codon and   
14.1 kb of sequence in the 3 untranslated region, revealed 61 
SNPs, of which 50 had been previously described. The 33 SNPs 
with a minor allele frequency > 20% were grouped into seven 
correlation (r2 = 0.8) bins (I–VII; Fig. 1). We selected 22 SNPs 
for further genotyping: at least two SNPs per bin and five SNPs 
not included in bins but with potential functional effects, as as-
sessed by in silico analysis. SNPs associated with HF (Table I) 
were SNPs rs1257705 (P = 0.02; odds ratio [OR] = 2.3) and 
rs12526196 (P = 0.02; OR = 2.2) in bin II, SNPs rs6918698   
(P = 0.02; OR = 2) and rs3037970 (P = 0.003; OR = 2.6) in 
bin III, SNPs rs1931002 (P = 0.004; OR = 2.3) and rs2151532 
(P = 0.02; OR = 2) in bin IV, SNP rs9402373 (P = 0.015; 
OR = 2) in bin VI, and SNP rs9399005 (P = 0.02; OR = 2.2). 
The  covariates  were  gender  (P  <  0.001),  exposure  (fishing 
years: P < 0.001; born on boat: P < 0.01), and number of anti-
schistosome treatments (P < 0.01).
SNP  rs3037970  excluded  rs6918698  in  a  multivariate 
analysis testing both SNPs simultaneously. Similarly, SNP 
rs1931002 excluded SNP rs2151532, and SNP rs1256196 
excluded SNPs rs1257705 and rs9399005. This indicated that 
SNPs  rs12526196,  rs30337970,  rs1931002,  and  rs9402373 
had the strongest association with HF. When all four SNPs 
were tested in the same regression model (Table I, bottom), 
SNPs rs12526196 (P = 0.007; OR = 3), rs9402373 (P = 
0.002; OR = 2.8), and rs1931002 (P = 0.002; OR = 2.8) 
were independently associated with HF. We also tested a 
more severe phenotype, which included advanced HF only if 
patients displayed evidence of portal hypertension. We found 
that SNPs rs9402373 (P = 0.005; OR = 2.6) and rs3037970 
(P = 0.05; OR = 2) were associated with this phenotype; JEM VOL. 206, October 26, 2009  2323
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Figure 1.  Correlation bins for CTGF and flanking regions in the fisherman sample. 33 markers were genotyped in 70 unrelated subjects, as  
described in Materials and methods. Correlations (r2 values) between SNPs were determined using Haploview software (available at http://www 
.broadinstitute.org/mpg/haploview). The darkest colors indicate the strongest correlations (bottom). Correlation bins (r2 > 0.8; middle) were as follows:  
bin I, SNPs rs6940184 and rs9493149; bin II, SNPs rs12527705 and rs12526196; bin III, SNPs rs6918698 and 3037970; bin IV, SNPs rs2151532 and 
rs1931002; bin V, SNPs rs9493150, rs11966728, and rs12198610; bin VI, SNPs rs7747601, rs7768619, and rs9402373; and bin VII, SNPs rs12527379 and 
rs2095252. p-values obtained in the association studies with the 25 selected SNPs in Table I are shown (top).2324 CTGF AND SEVERE HEPATIC FIBROSIS | Dessein et al.
able to bind to RUSH1-alfa (94.3%), FOXC1 (90.2%), Dof2 
(88.8%), Dof3 (96.6%), MNB1A (93.2%), PBF (96%), and 
Mafb (85.3%). The rs12526196C allele may not specifically 
bind one transcription factor whereas the rs12526196T allele 
may specifically bind Foxq1 (87.6%), SRY (91%), FOXL1 
(86.8 and 85.8%), SOX9 (85.6%), Sox5 (87.5%), and Sox17 
(88%). To confirm these findings, we performed EMSA ex-
periments; EMSA also showed a greater binding affinity of 
nuclear factors for the rs12526196T allele (Fig. 3 A). The 
rs9402373 C allele also bound nuclear factors that were not 
bound by the G allele (Fig. 3 B). This binding was competed 
with a specific unbiotinylated probe (Fig. 3 B). EMSA did 
not  reveal  allele-specific  binding  for  the  rs12527705  and 
rs1931002 polymorphisms (Fig. 3 A).
We show in this report that two SNPs in the CTGF gene 
are  associated  with  severe  HF  across  various  populations. 
This result is remarkable given the fact that these populations 
are  ethnically  different  and  are  infected  by  two  different 
schistosome species. However, this result was not completely 
unexpected, as this gene belongs to a chromosomal region 
associated by us (Dessein et al., 1999) and others (Blanton et al., 
2005), with aggravated fibrosis in a Sudanese population 
CC genotype was associated with severe fibrosis (P = 2 × 106; 
OR = 2.01; confidence interval of OR [CI] = 1.51–2.68). 
We also performed a meta-analysis with SNP rs12526196 
on the data obtained in both the fisherman and farmer 
Chinese samples and in the Sudanese sample. This indicated 
that the TT genotype is associated with HF in these popula-
tions (P = 6 × 104; OR = 1.93; CI = 1.3–2.8).
To further support our findings, we tested, in Chinese 
fishermen, whether any SNPs within 7 Mb around CTGF 
were correlated (r2 > 0.6) with the SNPs associated with 
HF  (Fig.  2),  and  could  account  for  the  association.  We 
found no correlation.
rs9402373 and rs12526196 polymorphisms affect nuclear 
factor binding and may alter gene transcription  
or transcript stability
The associated polymorphisms may create or alter DNA–
protein interactions. We performed an in silico analysis 
(http://jaspar.cgb.ki.se) using an 85% threshold cut-off score 
(similarity matrix). DNA carrying the rs9402373C allele may 
bind specifically to BRAC1 (86.7% homology) and Broad-
Complex 3 (89.4%). The rs9402373G allele appears to be 
Table I.  SNPs in the region flanking CTGF are associated with severe HF in two Chinese samples
Chinese fishermen Chinese farmers
SNP Position Bins Genotype Controls Cases OR 95% CI P Controls Cases OR 95% CI P
% % % %
Univariate 
analysis
rs1257705 132304944 II AA 69.1 83.7 2.26 1.13–
4.5
0.02 65.1 72 1.67 0.98–
2.84
0.06
rs12526196 132305169 II TT 67.9 82.5 2.21 1.13–
4.4
0.02 61.6 71.8 1.85 1.1–  
3.1
0.02
rs9399005 132310657 CC 17.2 26.3 2.2 1.1–
4.29
0.02 NS
rs6918698 132314950 III CC 26.6 35.1 2 1.1–  
3.7
0.02 NS
rs3037970 132316891 III / 27.3 38.8 2.59 1.4–  
4.8
0.003 NS
rs1931002 132320175 IV CC 52.5 66.7 2.32 1.3–
4.13
0.004 NS
rs2151532 132316423 IV AA 55.4 65 1.98 1.12–
3.5
0.02 NS
rs9402373 132319124 VI CC 50.3 60.6 2.04 1.15–
3.54
0.015 25 43.1 2.23 1.32–
3.76
0.003
Multivariate 
analysis
rs12526196 II TT 3 1.4–  
6.6
0.007 1.88 1.13–
3.19
0.018
rs9402373 VI CC 2.8 1.5–  
5.4
0.002 2.26 1.33–
3.83
0.03
rs1931002 IV CC 2.81 1.47–
5.37
0.002
Data are provided for two independent Chinese samples (fishermen and farmers living in a region endemic for S. japonicum). Cases and controls were defined as 
indicated in Materials and methods and in Table S1. The association between genotypes and HF phenotypes were first tested separately (univariate analysis) and then 
simultaneously (multivariate analysis that included SNPS rs12526196, rs1931002, rs3037970, and rs9402373, which showed the strongest associations when tested 
against SNPs from the same bin). Bins represented correlation (r2 > 0.8) groups, and genotype was the aggravating genotype. In the Chinese fisherman sample (n = 300, 
99 cases and 201 controls), the covariates were the number of years of fishing, being born on a boat, sex, and the number of Praziquantel treatments. In the Chinese 
farmer sample (n = 294, 113 controls and 181 cases), the covariates were age, whether HF was endemic or not endemic, and whether they had been infected with HBV 
(P = 0.05; OR = 2.38). P, p-value.JEM VOL. 206, October 26, 2009  2325
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rs1256196 and rs9402373 also modulate HF caused by HBV 
and/or HCV, even though Hepatitis virus infections have 
likely aggravated HF in certain study subjects.
SNP rs9402373 was associated with HF in all four sam-
ples tested. This association was obtained in Chinese and 
Sudanese subjects by using a strict fibrosis phenotype or a 
more severe phenotype (HF plus evidence of portal blood 
hypertension). SNP rs1256196 was also independently asso-
ciated with HF in Chinese and Sudanese subjects. Our 
EMSA data indicated that allelic variants of SNPs rs1256196 
and rs9402373 bind differently to nuclear factors, suggesting 
that they may affect the regulation of gene transcription or 
the stability of transcripts.
During the course of our study, SNP rs6918698 has been 
shown to be associated with sclerodermia in Caucasians (Fonseca 
et al., 2007). Two other groups have failed to replicate this 
finding (Gourh et al., 2008; Morita et al., 2008). Our find-
ings of an association of HF with rs6918698CC in Brazilians 
and in Chinese fishermen were not replicated in the two 
other samples, and the rs6918698CC genotype is not the 
aggravating phenotype in sclerodermia. Thus, SNP rs6918698 
may be in linkage disequilibrium with another causal SNP.
CTGF is a major profibrogenic growth factor, playing a 
major  role  in  chondrogenesis  and  angiogenesis;  indeed, 
CTGF/ newborn mice die of skeletal defects (Ivkovic et al., 
2003; Gressner and Gressner, 2008). CTGF contributes to 
fibrosis  by  acting  in  synergy  with  various  profibrogenic 
growth factors (Leask and Abraham, 2006), including platelet-
derived growth factor, vascular endothelial growth factor, 
and the master fibrogenic molecule, TGF-. CTGF is a 
originating from West Africa and in an Arabic population in 
Egypt. Nevertheless, minor SNP alleles, such as the T allele 
of SNP rs12526196, were present at a low frequency in   
Sudanese and Brazilians, and our study may have lacked the 
statistical power to detect clear associations between these 
SNPs and fibrosis in these samples.
In cases in which covariates could be evaluated accurately, 
our analysis included those potentially affecting the fibrosis 
phenotype in the analysis. Accounting for nongenetic covari-
ates slightly improved the association in all cases. Nevertheless, 
the effects of all covariates (except for HBV infections) on the 
genetic associations reported in this paper were modest.
This is in part caused by the fact that we selected popula-
tions with high exposure (males and females) to infection. 
This is illustrated in the results of the meta-analysis that was 
performed without including the covariates, and confirmed 
the associations of SNPs rs12526196 and rs9402373 with HF. 
Nevertheless, past or present HBV infections had a significant 
effect on the genetic associations (HBV and HCV infections 
were tested if a suitable treatment of the affected subjects 
could be performed by the local health authority). Such a 
significant effect is possibly caused by the fact that HBV in-
fections aggravate HF and portal hypertension, thus con-
founding the genetic effect: a subject with a protective allele 
may have a more severe case of disease if he had been in-
fected by both schistosome and HBV.
In this regard, HBV or HCV infections do not cause peri-
portal fibrosis detectable by ultrasound. Thus, the genetic 
control described in this report relates to HF caused by schis-
tosomes.  Our  results  do  not  allow  concluding  that  SNPs 
Table II.  SNPs in the region flanking CTGF are associated with severe HF in Sudanese and Brazilian subjects infected  
with S. mansoni
Sudanese sample Brazilian sample
SNP Genotype Controls Cases OR 95% CI P SNP Genotype Controls Cases OR 95% CI P
% % % %
Univariate 
analysis
rs1257705 AA 90.1 98.4 6.68 0.86–
51.7
0.069 rs1257705 AA NS
rs12526196 TT 90.2 98.4 6.8 0.89–
52.8
0.066 rs12526196 TT NS
rs3037970 / NS rs3037970 / 80.5 90.2 0.12
rs6918698 CC NS rs6918698 CC + CG 63 83.9 3.05 1.33–
6.98
0.008
rs9402373 CC 78.1 94.9 5.22 1.53–
17.7
0.008 rs9402373 CC 61.3 80.3 2.57 1.18–
5.64
0.018
Multivariate 
analysis
rs12526196 TT 7.26 0.93–
56.8
0.059 rs6918698 CC 4.92 2–  
12
5 × 
104
rs9402373 CC 5.23 1.5–  
18
0.008 rs9402373 CC 4.25 1.79–
10.08
9 × 
104
The two principal schistosome strains that cause HF are S. japonicum in Asia and S. mansoni in Africa and South America. We investigated whether HF in an S. mansoni–
endemic region in Sudan and Brazil was also affected by CTGF allelic variants. CTGF polymorphisms that were associated with HF in Chinese fishermen were genotyped in 
both samples. Case and control phenotypes are described in Materials and methods and in Table S1. We first tested for associations between the SNPs and HF 
phenotypes separately (univariate analysis); the SNPs were then tested simultaneously (multivariate analysis), including SNPs rs12526196, rs1257705, and rs9402373. 
Genotype is the aggravating genotype. In Sudanese farmers (n = 214, 62 cases and 152 controls), the covariate was age only. In Brazilians (n = 136, 61 cases and  
75 controls), there were no covariate. P, p-value.2326 CTGF AND SEVERE HEPATIC FIBROSIS | Dessein et al.
induced pathology. CTGF may contribute to the massive 
hepatic angiogenesis observed in schistosome-infected sub-
jects and may participate in the development of hepatocarci-
noma in schistosomiasis patients.
Our report of an association between CTGF polymor-
phisms and severe fibrosis does not rule out the possibility 
that polymorphisms in other pathways also affect fibrosis pro-
gression. In this regard, there are several studies with various 
experimental models that show that IL-13 has a major pro-
fibrotic effect in mice infected with S. mansoni. Several human 
studies have also shown that polymorphisms in IL-13 or 
IL-13 receptor chains are associated with aggravated fibrosis, 
such as in sclerodermia (Granel et al., 2006a; Granel et al., 
2006b). In human schistosomiasis, Joseph et al. (2004) have 
reported an increased production of IL-13 by white blood 
cells stimulated by schistosome egg antigens in cultures from 
subjects with advanced disease. IFN- production was asso-
ciated  with  HF  in  S.  mansoni–infected  Sudanese  subjects; 
also, polymorphisms in IFN- that reduce IFN- production 
were associated with increased HF (Henri et al., 2002; 
TGF- downstream modulator (Leask and Abraham, 2003; 
Leask and Abraham, 2006). It increases TGF- binding to its 
receptor, interferes with the negative Smad-7 feedback loop 
affecting TGF- (Wahab et al., 2005), and inhibits receptor 
binding of the principal TGF- antagonist BPM-7 (Abreu   
et al., 2002). An important consequence of CTGF action on 
TGF- is the stimulation of transdifferentiation of hepatic 
stellate  cells  and  other  parenchymal  cells  into  ECMP- 
producing myofibroblasts, all of which are involved in fibro-
sis (Kalluri and Neilson, 2003; Neilson, 2005). CTGF also 
increases ECMP networking through its binding to fibronectin 
domains on ECMP (Yoshida and Munakata, 2007; Gressner 
and Gressner, 2008). Inhibiting CTGF with siRNAs pre-
vents or reduces rat tissue fibrosis (Li et al., 2006; George and 
Tsutsumi, 2007). Thus, CTGF is a major actor in fibrosis, 
and polymorphisms in CTGF could certainly affect HF in 
schistosome infections. In addition to profibrogenic effects, 
other CTGF properties, such as stimulation of angiogenesis 
(Shimo et al., 2001; Brigstock, 2002), stimulation of cell pro-
liferation (Gao et al., 2004), and survival (Croci et al., 2004), 
partly mediated through its effect on TGF- and BPM-7, 
may also be directly relevant to other aspects of schistosome-
Figure 2.  No other SNPs were correlated with SNPs rs12527705, 
rs12526196, rs9402373, and rs12527379 (r2 > 0.6) for the whole 
6q22–q23 region in Chinese subjects. (A) Physical map of the 6q22–
q23 region, indicating all the genes. (B) Correlation (r2) between SNPs 
rs12527705, rs12526196, rs9402373, and rs12527379 and the 6,896 
recorded polymorphisms in the 6q22–q23 (7-Mb) region surrounding 
CTGF. The genotypes were downloaded from the HapMap project (Chinese 
reference population).
Figure 3.  EMSA for SNPs rs12526196, rs9402373, rs12527705, 
and rs1931002. (A) EMSA was performed according to Materials and 
methods using nuclear extracts of a stimulated human hepatocyte cell 
line (HEPG2). The 12526196T allele bound nuclear factors (complex 1) 
with a higher affinity than the C allele. The SNP rs9402373C allele bound 
nuclear factors (complex 2) that were not bound by the G allele. No allele-
specific binding was observed with SNPs rs12527705 and rs1931002.  
(B) Competitive reactions performed with 100 (5×) or 200 (10×) fmol of 
unbiotinylated rs9402373G and C probe. The unbiotinylated rs9402373G 
did not compete with the biotinylated rs9402373C probe for binding.JEM VOL. 206, October 26, 2009  2327
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whereas half of the farmers had an active or cured HBV infection. Covari-
ates affecting HF in fishermen were exposure, gender, and the number of 
antischistosome treatments. Exposure included two covariates: the number 
of years fishing and being born on a boat. Covariates affecting HF in Chi-
nese farmers were age, gender, HBV infections, and whether the farming 
place was endemic. The covariate affecting HF in Sudanese was age only. 
No covariates were identified in Brazilian cases and controls who were 
matched for age, gender, and exposure.
The meta-analysis was performed with Comprehensive Meta Analysis 
Version 2 (available at www.Meta-Analysis.com) on data obtained without 
including covariates; the strength of the recorded genetic associations was 
slightly lower in the absence of the nongenetic covariates.
DNA. DNA was extracted from 3-ml blood samples using the standard 
salting-out method (Sambrook et al., 1989). In a few cases, buccal cell samples 
were collected and DNA was extracted and preamplified as previously described 
(He et al., 2007, 2008).
Sequencing. Purified PCR products were sequenced using a cycle sequenc-
ing system (BigDye Terminator; Applied Biosystems) on an automatic se-
quencer (Prism; Applied Biosystems). Sequencing reactions were performed 
on both strands (Table S2). Sequencing was performed by GATC Biotech.
Polymorphism genotyping. The SNPs rs9321314, rs9321315, rs6910279, 
rs6940184, rs12523697, rs9493149, rs12529636, rs12527705, rs12526196, 
rs6917644,  rs9399005,  rs6918698,  rs9493150,  rs2151532,  rs3037970, 
rs928501, rs11966728, rs7747601, rs12198610, rs9402373, 132319925 D/I, 
rs1931002, rs12527379, rs9483364, and rs2095252 were genotyped using 
probe  assays  (TaqMan;  Applied  Biosystems).  Polymorphisms  rs6926879, 
rs341188377, rs1931003, rs12191459, rs12206863, rs7768619, rs10872386, 
and rs2327184 were genotyped by restriction enzyme analysis (Table S3).
Nuclear extract preparation. Nuclear extracts were prepared using nuclear 
and cytoplasmic component extraction reagents (NE-PER; Thermo Fisher 
Scientific) from a human hepatocyte cell line (HEPG2), stimulated for 1 h 
with 1 mM dexamethasone (Kobayashi et al., 2005; Gressner et al., 2007).
EMSA  Complementary  single-stranded  oligonucleotides  were  commer-
cially synthesized to span 10 bp on either side of the variant nucleotide, 
as  follows:  rs9402373C,  5-GCTCTCAAAACTAAGCCCAACTC-3; 
rs9402373G, 5-GCTCTCAAAAGTAAGCCCAACTC-3; rs12527705A, 
5-GTAATATAGAAGATGGGTCTA-3;  rs12527705T,  5-GTAATATA-
GATGATGGGTCTA-3; rs12526196C, 5-GAATATACAACGAATAT-
GGGC-3;  rs12526196T,  5-GAATATACAATGAATATGGGC-3; 
rs1931002A, 5-TGGATGATTCAAACAACTTGG-3; and rs1931002G, 
5-TGGATGATTCGAACAACTTGG-3.  Experiments  follow  a  previ-
ously described protocol (He et al., 2008).
Online supplemental material. HF was evaluated according to the 
WHO guidelines. The criteria for cases and control definitions are described 
in Table S1. We sequenced CTGF (3.2 kb) and 15.3 kb of sequence up-
stream from the start codon and 14.1 kb of sequence in the 3 untrans-
lated region in eight cases and two controls: sequencing revealed 61 SNPs, 
50 of which had been described previously. The sequencing primers are 
described in Table S2. Several polymorphisms were genotyped by restric-
tion enzyme analysis under standard conditions. Primers are described in 
Table  S3.  Online  supplemental  material  is  available  at  http://www.jem 
.org/cgi/content/full/jem.20090383/DC1.
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Chevillard et al., 2003). Interestingly, the inhibitory effect of 
IFN- on stellate cell differentiation into myofibroblasts in-
volves a Stat1-mediated down-regulation of CTGF expres-
sion (Fitzner et al., 2007).
In conclusion, this is the first report of the association be-
tween two independent polymorphisms and HF, identifying 
the most critical steps in disease development and indicating 
new therapeutic targets. It also provides valuable markers of 
HF progression.
MATERIALS AND METHODS
Study samples. Chinese fishermen were recruited (fisherman sample) on 
boats, whereas farmers (farmer sample) were recruited from hospital records 
(cases) or directly from their farms or villages (controls). Fishermen live on 
boats and/or on islands. They were highly exposed to infection, whereas 
most farmers were infected a long time ago, as parasite transmission in most 
fields was stopped 15 yr ago. Fishermen are mostly from Jiangshu province, 
and a few of them are from Hubei and Jiangxi. Farmers have been living in 
the Hunan province for several generations, and some of them originate 
from the mountain area. The Sudanese sample was recruited from farmers 
living in villages of the Gezira region (Dessein et al., 1999). The Brazilian 
sample was recruited in a village in northeast Brazil among subjects with high 
exposure to infected waters.
Evaluation of HF and case/control definition. HF was evaluated ac-
cording to the World Health Organization (WHO) guidelines modified as 
indicated for S. japonicum infections (Arnaud et al., 2008).
In S. japonicum infections, HF may be central (thick central fibrosis re-
fers to grades CLH, D, E, or F) or peripheral (thick peripheral fibrosis refers 
to grades GNH or GW). Advanced central and advanced peripheral fibrosis 
are noted as CLM and GNM, respectively.
In S. mansoni infections, HF is mostly central (thick central fibrosis refers 
to grades D, E, and F), and grade C indicates linear thickening of the portal 
vein. When schistosome transmission was lower, as in the Brazilian samples, 
the most advanced cases have grade C fibrosis and <2% of subjects exhibit 
grades D, E, or F. Enlarged portal vein diameter, varicose veins, and ascites 
can be used to identify the most severe cases unless study subjects have re-
ceived many antischistosome treatments. An enlarged portal vein diameter 
can be taken as evidence of portal hypertension and, when combined with 
advanced or severe HF, indicates a severe disease. Likewise, the presence of 
varicose veins and/or ascite indicates portal hypertension and severe disease. 
The human protocols were approved by the Research Ethical Committees 
of the University of Gezira and the National Cancer Institute (Gezira,   
Sudan), of the Hunan Institute of Parasitic Diseases (Yueyang, China), and 
of the University do Triangulo Mineiro (Ubéraba, Brazil).
Statistical analysis. Multivariate logistic regression (SPSS statistical soft-
ware version 10.0) was used to analyze the relationship between the proba-
bility  of  an  individual  developing  hepatic  disease  and  genetic  variants. 
Covariates that are known to affect HF in infected individuals were also 
added in the analysis subjects, as follows. (a) Age for all samples but Brazil-
ians. (b) Gender for Chinese (Sudanese and Brazilian cases and controls 
were matched for gender). (c) The number of Praziquantel (Bayer Pharma) 
treatments (only in Chinese fishermen, because all Chinese farmers had re-
ceived a large number of treatments that could not be accurately evaluated; 
only a few Brazilians and Sudanese had received a few treatments, and this 
had no detectable impact on HF). (d) Exposure was measurable with Chi-
nese fishermen but not with subjects from other samples who have been 
exposed very frequently to infection because of their daily farming activity. 
Nevertheless, the place of farming (whether it was still endemic or not) was 
a significant covariate for HF in Chinese farmers. (e) HBV and HCV infec-
tions could only be evaluated in Chinese farmers (HBV and HCV infections 
were tested if treatment could be provided by the local health authority); 
three Chinese farmers were infected with HCV and were not included, 2328 CTGF AND SEVERE HEPATIC FIBROSIS | Dessein et al.
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